Oil junior Melbana speeds up planning for Beehive-1 drilling

|

Published 03-DEC-2018 11:02 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

ASX small cap, Melbana Energy (ASX:MAY), has reached an agreement with its farm-in-partners, Total and Santos, to accelerate planning for the Beehive-1 exploration well, ensuring that it's ready to drill in the September quarter of 2020.

French oil and gas major, Total, and Australia's Santos have an option (exercisable together or individually) to acquire a direct 80% participating interest in the permit, in return for continuing to fully fund the costs of all activities until completion of the first well in the WA-488-P permit.

WA-488-P is located in the Bonaparte Gulf between the producing Blacktip gas field and the undeveloped Turtle and Barnett oil discoveries, and has an area of more than 4000 square kilometres.

One of the largest undrilled hydrocarbon prospects in Australia, the giant Beehive prospect itself was recently assessed by independent expert, McDaniel & Associates, to contain a best estimate prospective resource of 388 million barrels of oil equivalent, as below:

Source: MAY

Prospective Resources Cautionary Statement: The estimated quantities of petroleum that may potentially be recovered by the application of a future development project(s) relate to undiscovered accumulations. These estimates have both an associated risk of discovery and a risk of development. Future exploration appraisal and evaluation is required to determine the existence of a significant quantity of potentially moveable hydrocarbons.

Highlighting the fact that Total and Santos took the initiative to streamline the process, Melbana’s chief executive, Robert Zammit, said: “We welcome these changes to the commercial arrangement that accelerates drilling planning at the expense of further seismic processing.

“The changes were initiated by Total and Santos and are an illustration of their desire to progress evaluation of Beehive on a timely basis and ensure readiness to drill the Beehive-1 well in the September quarter of 2020, should they exercise their option to do so.”

Data to be received in early 2019

The agreement provides for Total and Santos to undertake preliminary well planning activities between February and July 2019, as required to ensure the viability of spudding the Beehive-1 exploration well during the September quarter of 2020, in case of option exercise, including drafting of an environment plan, well concept identification and commencement of rig selection activity.

The requirement of Total and Santos to undertake additional advanced seismic processing has been removed as it was regarded as no longer necessary to prepare for drilling.

Drilling data a potential share price catalyst

Data is expected to be received early in 2019, and Melbana, Total and Santos have agreed to lock in a firm backstop date for acceptance of the seismic data to trigger the start of the 6-month window for exercise of their option.

If Total and/or Santos exercises their option to drill, Melbana retains a 20% interest in WA-488-P and is fully carried until the completion of drilling of the first well in the permit.

Melbana estimates that the cost of the Beehive-1 exploration well is indicatively in a range between US$40 million and US$60 million.

Beehive is located close to several existing facilities, including the Ichthys project and Blacktip field and pipeline, offering several options for future gas monetisation.

In the event of a commercial discovery, Melbana will repay carried funding from its share of cash flow from the Beehive field.

Melbana will have no repayment obligations for such carried funding in the event that there is no commercial discovery and development in WA-488-P.

Location of Beehive prospect


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X